Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540969 · ClinicalTrials.gov registry record · Phase 3
Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases
A Phase 3 study, sponsored by Alliance for Clinical Trials in Oncology.
- Terminated
- Registry status
- Phase 3
- Development phase
- 3
- Enrollment target
NCT00540969 is a Phase 3 study that was terminated before completion, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 3 participants.
The verdict
NCT00540969, a Phase 3 study, was terminated before completion, sponsored by Alliance for Clinical Trials in Oncology.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 3 participants
- Enrollment target
Study Summary
RATIONALE: Cryoablation kills cancer cells by freezing them. Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. It is not yet known whether cryoablation is more effective than external-beam radiation therapy in treating painful bone metastases. PURPOSE: This randomized phase III clinical trial is studying cryoablation to see how well it works compared with external-beam radiation therapy in treating patients with painful bone metastases.
Interventions
- RADIATION radiation therapy
- PROCEDURE cryosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00540969
The ClinicalTrials.gov registry entry for NCT00540969 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which radiation therapy is the first listed.
NCT00540969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00540969 about?
NCT00540969 is a clinical study titled "Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases". RATIONALE: Cryoablation kills cancer cells by freezing them. Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. It is not yet known whether cryoablation is more effective than external-beam radiation therapy in treating painful bone metastases. PURPOSE: This...
What is the current status of trial NCT00540969?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 3 participants. The study started on 2008-02. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00540969?
The interventions under investigation include: radiation therapy (RADIATION), cryosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT00540969?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.